Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,495,933 papers from all fields of science
Search
Sign In
Create Free Account
panepophenanthrin
Known as:
1,3a,10-trihydroxy-10c-(3-hydroxy-3-methylbut-1-enyl)-5,5-dimethyl-1,2,3,3a,5,5a,8,9,10,10a,10b,10c-dodecahydro-4-oxa-2,3,8,9-diepoxyacephenanthrylen-7-one
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Phenanthrenes
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Application of a tandem metathesis to the synthesis of (+)-panepophenanthrin.
Jingwei Li
,
Daesung Lee
Chemistry - An Asian Journal
2010
Corpus ID: 32840711
A novel total synthesis of (+)-panepophenanthrin (IV) via a tandem ring-closing metathesis/cross-metathesis sequence as key step…
Expand
2006
2006
P-538 TOTAL SYNTHESIS OF PANEPOPHENANTHRIN AND BIOLOGICAL ACTIVITIES OF ITS DERIVATIVES
M. Matsuzawa
,
Junichiro Yamaguchi
,
M. Shoji
,
H. Kakeya
,
H. Osada
,
Y. Hayashi
2006
Corpus ID: 94447450
2004
2004
Enantioselective total synthesis of (+)-Panepophenanthrin, a novel inhibitor of the Ubiquitin-activating enzyme
G. Mehta
,
S. Ramesh
2004
Corpus ID: 97497443
Highly Cited
2003
Highly Cited
2003
Total synthesis of the ubiquitin-activating enzyme inhibitor (+)-panepophenanthrin.
Xiaoguang Lei
,
Richard P. Johnson
,
J. Porco
Angewandte Chemie
2003
Corpus ID: 39753461
In 2002, the first natural product inhibitor of ubiquitin activating enzyme, panepophenanthrin (1), was isolated from the…
Expand
2003
2003
Total synthesis of panepophenanthrin.
J. Moses
,
Laurent Commeiras
,
J. Baldwin
,
R. Adlington
Organic Letters
2003
Corpus ID: 37472215
[reaction: see text] The biomimetic synthesis of the racemic dimer panepophenanthrin was achieved in good yield employing a…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE